05.30.23 -- Accelerate Your Cell And Gene Therapy Research

Are you looking for a small oligonucleotide synthesizer that's user friendly and supports scale up? Featuring a user-friendly interface, improved process control features, and compact footprint, the ÄKTA oligosynt™ oligonucleotide synthesizer is a small scale system with big impact.

Review the suggested method for adapting hPSCs originally cultured in StemFlex™ to NutriStem® hPSC Medium. For this transition, a simple and direct adaptation can be followed with cultures exhibiting similar morphology as well as higher levels of pluripotency when compared to StemFlex™.

Synthego's Robert Deans, Chief Scientific Officer, and Beckinam Nowatzke, Senior Director of Quality & Regulatory, will elaborate on our preclinical and GMP offerings that support CRISPR therapy developers and accelerate time to clinic.

With better analytical technologies, Waters and Sartorius are speeding the development process to bring new medicines and therapies to cancer patients faster and with fewer side effects.

Learn how two new Solentim products, an instrument named ICON™, designed to empower laboratories to make better decisions faster, and an overarching platform called STUDIUS™, work to provide a new data-driven workflow for the development of modern cell-based therapies.

Discover a one-stop-shop for LNP technologies that provides access to expertise in formulation and analytics for successful outcomes for payload and target applications. Explore end-to-end biopharma services and systems.

Formulated for the feeder-free expansion of human pluripotent stem cells in research and translational workflows, this serum-free defined media features all animal-free components to provide a stable and reproducible cell culture environment.